B
Bailard Portfolio holdings
AUM
$4.29B
This Quarter Return
+11.33%
1 Year Return
+18.39%
3 Year Return
+76.25%
5 Year Return
+133.74%
10 Year Return
+353.73%
AUM
$4.29B
AUM Growth
+$4.29B
(+11%)
Cap. Flow
+$77.1M
Cap. Flow
% of AUM
1.8%
Top 10 Holdings %
Top 10 Hldgs %
28.63%
Holding
861
New
126
Increased
253
Reduced
281
Closed
107
Top Buys
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
$79.5M |
| 2 |
iShares Short-Term National Muni Bond ETF
SUB
|
$15.1M |
| 3 |
Broadcom
AVGO
|
$12.8M |
| 4 |
JPMorgan Municipal ETF
JMUB
|
$12.2M |
| 5 |
iShares California Muni Bond ETF
CMF
|
$10.7M |
Top Sells
| 1 |
Vanguard Total Bond Market
BND
|
$78.2M |
| 2 |
JPMorgan Ultra-Short Municipal Income ETF
JMST
|
$18.2M |
| 3 |
iShares iBonds Dec 2026 Term Treasury ETF
IBTG
|
$12.3M |
| 4 |
NVIDIA
NVDA
|
$6.07M |
| 5 |
SPDR Portfolio Short Term Treasury ETF
SPTS
|
$5.95M |
Sector Composition
| 1 | Technology | 22.99% |
| 2 | Financials | 8.01% |
| 3 | Healthcare | 6.98% |
| 4 | Communication Services | 5.95% |
| 5 | Consumer Discretionary | 4.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
726
Portillo's
PTLO
$488M
| $193K | ﹤0.01% |
+16,500
| New | +$193K |
|
727
Fulcrum Therapeutics
FULC
$353M
| $185K | ﹤0.01% |
+26,881
| New | +$185K |
|
728
Organogenesis Holdings
ORGO
$629M
| $157K | ﹤0.01% |
42,913
| – | – |
|
|
ITOS
729
DELISTED
iTeos Therapeutics
ITOS
| $152K | ﹤0.01% |
+15,200
| New | +$152K |
|
730
Greenlight Captial
GLRE
$434M
| $147K | ﹤0.01% |
10,200
| – | – |
|
731
iShares Global Clean Energy ETF
ICLN
$1.54B
| $146K | ﹤0.01% |
11,099
| – | – |
|
732
Astria Therapeutics
ATXS
$394M
| $142K | ﹤0.01% |
+26,500
| New | +$142K |
|
733
SurgePays
SURG
$55.3M
| $141K | ﹤0.01% |
45,075
-405
| -0.9% | -$1.26K |
|
734
LXP Industrial Trust
LXP
$2.66B
| $134K | ﹤0.01% |
16,282
-58
| -0.4% | -$479 |
|
735
Vanda Pharmaceuticals
VNDA
$279M
| $123K | ﹤0.01% |
26,100
+3,631
| +16% | +$17.1K |
|
736
United Homes Group
UHG
$238M
| $116K | ﹤0.01% |
+40,084
| New | +$116K |
|
737
Ideal Power
IPWR
$43.4M
| $102K | ﹤0.01% |
22,540
-202
| -0.9% | -$915 |
|
738
Monte Rosa Therapeutics
GLUE
$309M
| $101K | ﹤0.01% |
+22,500
| New | +$101K |
|
739
Aurinia Pharmaceuticals
AUPH
$1.58B
| $99.1K | ﹤0.01% |
+11,700
| New | +$99.1K |
|
740
Agilon Health
AGL
$497M
| $97K | ﹤0.01% |
42,157
-378
| -0.9% | -$869 |
|
741
MindMed
MNMD
$689M
| $94.8K | ﹤0.01% |
14,600
| – | – |
|
742
Protara Therapeutics
TARA
$125M
| $90.2K | ﹤0.01% |
29,769
| – | – |
|
743
Ventyx Biosciences
VTYX
$184M
| $88.4K | ﹤0.01% |
+41,300
| New | +$88.4K |
|
|
LFT
744
Lument Finance Trust
LFT
$119M
| $87.4K | ﹤0.01% |
39,525
+21,474
| +119% | +$47.5K |
|
|
NHS
745
Neuberger Berman High Yield Strategies Fund
NHS
$229M
| $82.2K | ﹤0.01% |
10,839
| – | – |
|
746
SIGA Technologies
SIGA
$617M
| $77.6K | ﹤0.01% |
+11,900
| New | +$77.6K |
|
747
Editas Medicine
EDIT
$225M
| $74.5K | ﹤0.01% |
33,875
| – | – |
|
748
Aegon
AEG
$12.3B
| $74.4K | ﹤0.01% |
10,283
| – | – |
|
749
Ampco-Pittsburgh
AP
$58.5M
| $59K | ﹤0.01% |
19,934
+7,434
| +59% | +$22K |
|
750
Smart Sand
SND
$74.7M
| $49.8K | ﹤0.01% |
+24,800
| New | +$49.8K |
|